United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 16, 2026 · Filed Jun 17, 2026

On Jun 16, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$549.80 for US$5.22M under a trading plan, leaving 40,513 shares. Filed Jun 17, 2026 (Form 4).

Sold
9,500 shares
Price
US$549.80 average (US$545.18 to US$554.63)
Value
US$5.22M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 16, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 16, 2026Common StockSale173US$545.1849,840Direct
Jun 16, 2026Common StockSale525US$546.0449,315Direct
Jun 16, 2026Common StockSale542US$547.1248,773Direct
Jun 16, 2026Common StockSale2,027US$548.4246,746Direct
Jun 16, 2026Common StockSale1,113US$549.1345,633Direct
Jun 16, 2026Common StockSale2,036US$550.3243,597Direct
Jun 16, 2026Common StockSale1,797US$551.2841,800Direct
Jun 16, 2026Common StockSale691US$552.2941,109Direct
Jun 16, 2026Common StockSale386US$553.1040,723Direct
Jun 16, 2026Common StockSale210US$554.6340,513Direct

Source

View original at SEC

Related